CRISPR — Investment Biotechnology Sector: Keep a list of Companies

CRISPR is one of the most promising technologies of recent years, and in the coming years its role will only grow.

CRISPR / CAS9 — Powerful genome editing tool

For those investors who wish to invest in future biotechnology

BLUE (Bluebird Bio)

CELG (Celgene)

CRSP (CRISPR Therapeutics)

Edit (Edito Medicine)

ILMN (Illunina)

NTLA (Intellia Therapeutics)

ONCE (Spark Therapeutics)

SGMO (Sangamo Therapeutics)

VRTX (Vertex Pharmaceuticals)

And for fans of funds below, the most popular funds from the biotechnology sector.

Always analyze the paper and buy and sell only in accordance with your strategy.

You have no strategy yet?